XML 22 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT)
¥ in Thousands, $ in Thousands
Ordinary shares
CNY (¥)
shares
Ordinary shares
USD ($)
shares
Treasury stock
CNY (¥)
Treasury stock
USD ($)
Additional paid-in capital
CNY (¥)
Additional paid-in capital
USD ($)
Accumulated other comprehensive loss
CNY (¥)
Accumulated other comprehensive loss
USD ($)
Accumulated deficit
CNY (¥)
Accumulated deficit
USD ($)
Noncontrolling interests
CNY (¥)
Noncontrolling interests
USD ($)
Contingently redeemable noncontrolling Interest
CNY (¥)
CNY (¥)
USD ($)
Balance at Dec. 31, 2021 ¥ 105   ¥ (7)   ¥ 1,936,552   ¥ (29,496)   ¥ (3,277,270)   ¥ 433,055   ¥ 3,680,782 ¥ (937,061)  
Balance, shares at Dec. 31, 2021 | shares 130,251,685 130,251,685                          
Net loss                 (489,661)   (279,329)     (768,990)  
Other comprehensive income             1,730             1,730  
Accretion of contingently redeemable noncontrolling interests                     3,680,782   (3,680,782) 3,680,782  
Share-based compensation         (5,919)                 (5,919)  
Investment in equity instruments                     45,115     45,115  
Balance at Dec. 31, 2022 ¥ 105   (7)   1,930,633   (27,766)   (3,766,931)   3,879,623     2,015,657  
Balance, shares at Dec. 31, 2022 | shares 130,251,685 130,251,685                          
Net loss                 (297,658)   (233,363)     (531,021)  
Other comprehensive income             (37,653)             (37,653)  
Disposal partial interest of a subsidiary         (18,110)           18,110        
Capital injection from non-controlling shareholders         95,442           204,562     300,004  
Balance at Dec. 31, 2023 ¥ 105   (7)   2,007,965   (65,419)   (4,064,589)   3,868,932   0 1,746,987  
Balance, shares at Dec. 31, 2023 | shares 130,251,685 130,251,685                          
Net loss                 (308,243)   (343,832)     (652,075) $ (89,333)
Other comprehensive income             (11,930)             (11,930)  
Disposal partial interest of a subsidiary                     (1,640)     (1,640)  
Capital injection from non-controlling shareholders                     25,885     25,885  
Capital injection from initial public offering of Concord Healthcare Group Co., Ltd.         161,728           348,794     510,522  
Balance at Dec. 31, 2024 ¥ 105 $ 15 ¥ (7) $ (1) ¥ 2,169,693 $ 297,247 ¥ (77,349) $ (10,596) ¥ (4,372,832) $ (599,076) ¥ 3,898,139 $ 534,044 ¥ 0 ¥ 1,617,749 $ 221,633
Balance, shares at Dec. 31, 2024 | shares 130,251,685 130,251,685